News Focus
News Focus
Followers 0
Posts 324
Boards Moderated 0
Alias Born 03/01/2014

Re: RollitUpPlease post# 433

Tuesday, 04/22/2014 8:14:41 PM

Tuesday, April 22, 2014 8:14:41 PM

Post# of 4929
Investor's are waiting for the conference call to hear about the cost of the solvaldi drug. They are worried that they may not be able to maintain the price of solvaldi because law makers questioned the high cost. However, I think it's just all noise because sovaldi represents a major advance over existing treatments for hepatitis C. The new therapy can avoid the long-term medical expenses related to liver failure, cancer and transplants. I believe Gilead will be able to explain that to lawmakers and make them understand. If (I think when) this issue clears up, then this stock will explode to $100 IMO. I can't think of another company that has absolutely destroyed estimates like Gilead did this quarter. It's just absolutely amazing to see.
2014 PE just dropped to under 15 based on these earnings and rest of this year.2015 PE may well be under 10 at current $74 share price.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News